Siriuspoint Ltd SEC Filings

Capital Research Global Investors filed a Schedule 13G reporting beneficial ownership of 6,700,000 shares of SiriusPoint Ltd. (SPNT), representing 5.7% of the class as of the event date September 30, 2025.

The filer reports sole voting power: 6,700,000 and sole dispositive power: 6,700,000, with no shared voting or dispositive power. The percentage is based on 116,759,539 shares believed outstanding. The certification states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.

Wellington Management Group LLP, together with affiliated entities, filed an amended Schedule 13G reporting beneficial ownership in SiriusPoint Ltd. (SPNT).

They reported 4,297,864 shares beneficially owned, representing 3.68% of the common stock, as of the event date 09/30/2025. Wellington reported 0 shares with sole voting or dispositive power, 3,321,795 shares with shared voting power, and 4,297,864 shares with shared dispositive power.

The shares are owned of record by clients of Wellington’s investment adviser affiliates. Wellington stated that no single client is known to have rights to more than five percent of the class and certified the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

SiriusPoint Ltd. completed the previously announced sale of all membership interests in ArmadaCorp Capital, LLC, the holding company of its supplemental health insurance program manager ArmadaCare, to a subsidiary of Ambac Financial Group Inc.

The Seller received $250 million in cash consideration, subject to deductions including transaction expenses. The transaction closed after satisfaction of customary closing conditions.

SiriusPoint Ltd. (SPNT) reported a stronger quarter. Q3 revenue reached $755.9 million, up from $562.2 million a year ago, driven by higher net premiums earned of $647.7 million. Net income rose to $90.7 million versus $8.7 million, with diluted EPS of $0.73. Underwriting stayed profitable with a combined ratio of 89.1% and underwriting income of $91.4 million. Net investment income was $66.5 million.

The company agreed to sell ArmadaCorp Capital for $250 million, classifying it as held-for-sale and guiding to a pre-tax gain of $220–$230 million, subject to customary closing conditions and regulatory approvals in the fourth quarter of 2025. Operating cash flow improved to $128.8 million for the nine months, while financing cash outflows included $490.8 million of common share repurchases. Shareholders’ equity attributable to SiriusPoint rose to $2,209.9 million, helped by a swing in accumulated other comprehensive income to $52.3 million. Common shares outstanding were 116,814,640 as of October 29, 2025.

SiriusPoint Ltd. (SPNT) filed an 8-K stating it furnished its third-quarter 2025 results press release (Exhibit 99.1), a financial supplement (Exhibit 99.2), and an investor slide presentation (Exhibit 99.3). These materials were provided under Items 2.02 and 7.01 and are not deemed filed under the Exchange Act.

Under Item 8.01, the Audit Committee approved a quarterly cash dividend of $0.50 per share on the company’s 8.00% Resettable Fixed Rate Preference Shares, Series B, payable on November 28, 2025 to shareholders of record on November 13, 2025 (press release in Exhibit 99.4).

SiriusPoint (SPNT) announced a leadership change in finance. The company disclosed that Chief Accounting Officer and principal accounting officer Evan Cabat will resign effective October 31, 2025 to pursue another opportunity. The company stated his departure is not due to any disagreement with the Board or management on financial statements, internal controls, operations, policies, or practices.

Until the effective date, Mr. Cabat will continue in his role and support the transition. Upon his departure, Chief Financial Officer Jim McKinney will also serve as the company’s principal accounting officer, in addition to his role as principal financial officer.

The Vanguard Group reported beneficial ownership of 11,757,727 shares of SiriusPoint Ltd common stock, representing 10.07% of the class as of the 09/30/2025 event date. Vanguard states it has sole dispositive power over 10,889,144 shares and shared voting power for 723,042 shares, reflecting portfolio management and client-directed holdings rather than an intent to influence control. The filing clarifies that Vanguard's clients have the right to receive dividends or proceeds and that no single outside person holds more than 5% of the class through Vanguard-managed accounts. The statement is certified by Vanguard's Head of Global Fund Administration on 10/06/2025.

SiriusPoint Ltd disclosed an amendment to its program management agreement with Arcadian and an extension of the underwriting term to December 31, 2031. The filing indicates the board did not vote to disapprove the action, allowing the company to execute the amendment. The notice references a related press release dated October 6, 2025 and is signed by Chief Legal Officer Linda S. Lin. The disclosure is brief and focuses on the contractual extension and administrative approval status rather than financial results.